Michael Thomas Henderson Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Michael Thomas Henderson is Chief Business Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 274,211 shares of BBIO, which is worth approximately $6.32 Million. The most recent transaction as insider was on Dec 01, 2020, when has been sold 10,000 shares (Common Stock) at a price of $51.4 per share, resulting in proceeds of $514,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 274K

0% 3M change

0% 12M change

Total Value Held $6.32 Million

MICHAEL THOMAS HENDERSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2020	SELL Open market or private sale	$514,000 $51.4 p/Share	10,000 Reduced 3.52%	274,211 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$10,500 $1.05 p/Share	10,000 Added 3.4%	284,211 Common Stock
Nov 16 2020	SELL Open market or private sale	$450,000 $45.0 p/Share	10,000 Reduced 3.6%	267,751 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$281,629 $44.33 p/Share	6,353 Reduced 2.26%	274,211 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$23,954 $1.05 p/Share	22,813 Added 7.52%	280,564 Common Stock
Nov 02 2020	SELL Open market or private sale	$386,300 $38.63 p/Share	10,000 Reduced 3.6%	267,751 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$10,500 $1.05 p/Share	10,000 Added 3.48%	277,751 Common Stock
Oct 01 2020	SELL Open market or private sale	$387,900 $38.79 p/Share	10,000 Reduced 3.6%	267,751 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$6,700 $0.67 p/Share	10,000 Added 3.48%	277,751 Common Stock

Also insider at

APGE

Apogee Therapeutics, Inc.

Chief Executive Officer

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

ARYD

ARYA Sciences Acquisition Corp IV Financial Services

MTH